SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : MSFT Internet Explorer vs. NSCP Navigator -- Ignore unavailable to you. Want to Upgrade?


To: Daniel Schuh who wrote (18617)4/19/1998 7:18:00 PM
From: Gerald R. Lampton  Read Replies (1) | Respond to of 24154
 
Microsoft's existence depends on enforcement of intellectual property laws. Just like you and me, it has to obey the others, too -- it doesn't get to pick and choose.

Funny that you should mention intellectual property laws in the context of antitrust. In trying to find the Cato Institute article referred to in Post 18614, "Policy and Path Dependence," I ran across the following in an article which discusses the Microsoft Consent Decree case at length and argues that tying arrangements such as the Windows/IE tie should be legal:

"Some would argue that when a tying product is patent-protected, government should intervene to prohibit the tie-in if above-normal profits in the tied product market are thought to constitute excessive compensation for the research and development that patents are intended to reward. But that would mean government regulation of profits on everything from patented drugs to machinery to you name it -- a horrifying prospect worth avoiding at all cost."

cato.org

The article is somewhat dated in light of DOJ's ruminations about bringing a broader antitrust case and is definitely biased, but it is worth reading for a summary of the events surrounding the Consent Decree.



To: Daniel Schuh who wrote (18617)4/21/1998 5:42:00 PM
From: Eugene Goodman  Read Replies (2) | Respond to of 24154
 
Krugman and the Cato article say the the Theory of
Increasing Returns is the basis of the DOJ law suit.
I quote from the Cato article:

Taking one specific case, path dependence arguments
have been used to support antitrust actions against
Microsoft. A white paper by Gary Reback and a group of
coauthors, with assistance from Brian Arthur, uses path
dependence arguments to claim that Microsoft's successes
in the personal computer software market are due not to Microsoft's ability to provide consumers with handy
solutions to their problems, but instead are caused
by consumers' inabilities to escape from a path
controlled by Microsoft. Reback, et al. chillingly portray
the ominous end of that path: "It is difficult to imagine
that in an open society such as this one, with multiple
information sources, a single company could seize
sufficient control of information transmission so as to
constitute a threat to the underpinnings of a free society.
But such a scenario is a realistic (and perhaps probable)
outcome."


The theory is important to the DOJ because they are
breaking new ground. Microsoft does not have a controlling
market share. They do not hurt the consumer by charging
high prices. The DOJ law suit is based on what might
happen if the government does not help. Microsoft will
get a 70 % [isn't this what Netscape has now?] or higher
market share, then they raise their prices and screw the
helpless consumer. Since none of this is has happened, an
economic theory is essential to predict the future.
[Good luck. it will be a first] If the theory is flawed
so is their law suit.

If I remember correctly, none of this stuff is in the
Sherman Act. Anti-trust is based on prior case law. This
gives the Act flexibility and durability so that the
trustbusters can focus on consumer protection, vertical
or horizontal integration, price fixing or take a 12 year
vacation as as it seems they did under Reagen and Bush.

Anti-trust law is not immutablle so Microsoft will only
know to what extent they have broken the law after the
DOJ, the court and Microsoft come to an agreement.

Gene